Chronic methylphenidate treatment enhances striatal dopamine neurotransmission after experimental traumatic brain injury

Journal of Neurochemistry

Volumn 108, Issue 4, 2009, Pages 986-997

  Wagner, Amy K ^a,b   Drewencki, Laura L ^a,b   Chen, Xiangbai ^a,b   Santos, F Ryan ^a,b   Khan, Amina S ^a   Harun, Rashed ^a,b   Torres, Gonzalo E ^a   Michael, Adrian C ^c   Dixon, C Edward ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Dopamine; Methylphenidate; Neurotransmission; Striatum; Transcription factor; Traumatic brain injury; Voltammetry

Indexed keywords

DOPAMINE; DOPAMINE TRANSPORTER; METHYLPHENIDATE; PROTEIN C FOS; TYROSINE 3 MONOOXYGENASE; VESICULAR MONOAMINE TRANSPORTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; TRAUMATIC BRAIN INJURY;

ANIMALS; BRAIN INJURIES; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; DRUG ADMINISTRATION SCHEDULE; KINETICS; MALE; METHYLPHENIDATE; PRESYNAPTIC TERMINALS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTIC MEMBRANES; SYNAPTIC TRANSMISSION; TREATMENT OUTCOME; UP-REGULATION;

RATTUS;

EID: 58549116152     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05840.x     Document Type: Article

References (70)

1. Batchelor M. Schenk J. O. (1998) Protein kinase A activity may kinetically upregulate the striatal transporter for dopamine. J. Neurosci. 18, 10304 10309.
2. Bernstein E. M. Quick M. W. (1999) Regulation of gamma-aminobutyric acid (GABA) transporters by extracellular GABA. J. Biol. Chem. 274, 889 895.
3. Borland L. M. Michael A. C. (2004) Voltammetric study of the control of striatal dopamine release by glutamate. J. Neurochem. 91, 220 229.
4. Brandon C. L. Steiner H. (2003) Repeated methylphenidate treatment in adolescent rats alters gene regulation in the striatum. Eur. J. Neurosci. 18, 1584 1592.
5. Bungay P. M., Newton-Vinson P., Isele W., Garris P. A. Justice J. B. (2003) Microdialysis of dopamine interpreted with quantitative model incorporating probe implantation trauma. J. Neurochem. 86, 932 946.
6. Canales J. J. Graybiel A. M. (2000) Patterns of gene expression and behavior induced by chronic dopamine treatments. Ann. Neurol. 47, S53 S59.
7. Chase T. D., Brown R. E., Carrey N. Wilkinson M. (2003) Daily methylphenidate administration attenuates c-fos expression in the striatum of prepubertal rats. Neuroreport 14, 769 772.
8. Crawford C. A., McDougall S. A., Meier T. L., Collins R. L. Watson J. B. (1998) Repeated methylphenidate treatment induces behavioral sensitization and decreases protein kinase A and dopamine-stimulated adenylyl cyclase activity in the dorsal striatum. Psychopharmacology 136, 34 43.
9. Dash P. K., Moore A. N. Dixon C. E. (1995) Spatial memory deficits, increased phosphorylation of the transcription factor CREB, and induction of the AP-1 complex following experimental brain injury. J. Neurosci. 15, 2030 2039.
10. Dixon C. E., Clifton G. L., Lighthall J. W., Yaqhmai A. A. Hayes R. L. (1991) A controlled cortical impact model of traumatic brain injury in the rat. J. Neurosci. Methods 39, 253 262.
11. Donnemiller E., Brenneis C., Wissel J., Scherfler C., Poewe W., Riccabona G. Wenning G. K. (2001) Impaired dopaminergic neurotransmission in patients with traumatic brain injury: a SPECT study using 123I-beta-CIT and 123I-IBZM. Eur. J. Nucl. Med. 27, 1410 1414.
12. Dunn-Meynell A. A. Levin B. E. (1997) Histological markers of neuronal, axonal and astrocytic changes after lateral rigid impact traumatic brain injury. Brain Res. 761, 25 41.
13. Fleckenstein A. E., Volz T. J. Hanson G. R. (2008) Psychostimulant- induced alterations in vesicular monoamine transporter-2 function: neurotoxic and therapeutic implications. Neuropharmacology [Epub ahead of print] doi :.
14. Foster J. D., Pananusorn B. Vaughan R. A. (2002) Dopamine transporters are phosphorylated on N-terminal serines in rat striatum. J. Biol. Chem. 277, 25178 25186.
15. Garris P. A. Wightman R. M. (1994) Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study. J. Neurosci. 14, 442 450.
16. Garris P. A., Walker Q. D. Wightman R. M. (1997) Dopamine release and uptake rates both decrease in the partially denervated striatum in proportion to the loss of dopamine terminals. Brain Res. 753, 225 234.
17. Geerlings A., Núñez E., López-Corcuera B. Aragón C. (2001) Calcium- and syntaxin 1-mediated trafficking of the neuronal glycine transporter GLYT2. J. Biol. Chem. 276, 17584 17590.
18. Graybiel A. M., Moratalla R. Robertson H. A. (1990) Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl Acad. Sci. USA 87, 6912 6916.
19. Greco G. G. Garris P. A. (2003) In vivo interaction of cocaine with the dopamine transporter as measured by voltammetry. Eur. J. Pharmacol. 479, 117 125.
20. Hawken C. M., Brown R. E., Carrey N. Wilkinson M. (2004) Long-term methylphenidate treatment down-regulates c-fos in the striatum of male CD-1 mice. Neuroreport 15, 1045 1048.
21. Hersch S. M., Yi H., Heilman C. J., Edwards R. H. Levey A. I. (1997) Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra. J. Comp. Neurol. 388, 211 227.
22. Hoffman B. J., Hansson S. R., Mezey E. Palkovits M. (1998) Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system. Front Neuroendocrinol. 19, 187 231. Review.
23. Hope B., Kosofsky B., Hyman S. E. Nestler E. J. (1992) Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine. Proc. Natl Acad. Sci. USA 89, 5764 5768.
24. Jones S. R., Joseph J. D., Barak L. S., Caron M. G. Wightman R. M. (1999) Dopamine neuronal transport kinetics and effects of amphentamine. J. Neurochem. 73, 2406 2414.
25. Kilbourn M. R., Frey K. A., VanderBorght R. Sherman P. S. (1996) Effects of dopaminergic treatment on in vivo radioligand binding to brain vesicular monoamine transporters. Nucl. Med. Biol. 23, 467 471.
26. Kline A. E., Yan H. Q., Bao J., Marion D. W. Dixon C. E. (2000) Chronic methylphenidate treatment enhances water maze performance following traumatic brain injury in rats. Neurosci. Lett. 280, 163 166.
27. Kulgina N. V., Zigmond M. J. Michael A. C. (2001) Glutamate regulates the spontaneous and evoked release of dopamine in the rat striatum. Neuroscience 19, 121 128.
28. Kumer S. C. Vrana K. E. (1996) Intricate regulation of tyrosine hydroxylase activity and gene expression. J. Neurochem. 67, 443 462.
29. Lee K. H., Kim M. Y., Kim D. H. Lee Y. S. (2004) Syntaxin 1A and receptor for activated C kinase interact with the N-terminal region of human dopamine transporter. Neurochem. Res. 29, 1405 1409.
30. Li L. B., Chen N., Ramamoorthy S. et al. (2004) The role of N-glycosylation in function and surface trafficking of the human dopamine transporter. J. Biol. Chem. 279, 21012 21020.
31. Lin J. S., Hou Y. Jouvet M. (1996) Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. Proc. Natl Acad. Sci. USA 93, 14128 14133.
32. Lindgren N., Xu Z. Q., Lindskog M., Herrera-Marschitz M., Goiny M., Haycock J., Goldstein M., Hökfelt T. Fisone G. (2000) Regulation of tyrosine hydroxylase activity and phosphorylation at Ser(19) and Ser(40) via activation of glutamate NMDA receptors in rat striatum. J. Neurochem. 74, 2470 2477.
33. Lindgren N., Xu Z. Q., Herrera-Marschitz M., Haycock J., Hökfelt T. Fisone G. (2001) Dopamine D(2) receptors regulate tyrosine hydroxylase activity and phosphorylation at Ser40 in rat striatum. Eur. J. Neurosci. 13, 773 780.
34. May L. J. Wightman R. M. (1989) Heterogeneity of stimulated dopamine overflow within rat striatum as observed with in vivo voltammetry. Brain Res. 487, 311 320.
35. Michael D. J. Wightman R. M. (1999) Electrochemical monitoring of biogenic amine neurotransmission in real time. J. Pharm. Biomed. Anal. 19, 33 46.
36. Miranda M., Dionne K. R., Sorkina T. Sorkin A. (2007) Three ubiquitin conjugation sites in the amino terminus of the dopamine transporter mediate protein kinase C-dependent endocytosis of the transporter. Mol. Biol. Cell 18, 313 323.
37. Moll G. H., Hause S., Ruther E., Rothenberger A. Huether G. (2001) Early methylphenidate administration to young rats causes a persistent reduction in the density of striatal dopamine transporters. J. Child Adolesc. Psychopharmacol. 11, 15 24.
38. Mortensen O. V. Amara S. G. (2003) Dynamic regulation of the dopamine transporter. Eur. J. Pharmacol. 479, 159 170.
39. Munir M., Correale D. M. Robinson M. B. (2000) Substrate-induced up-regulation of Na(+)-dependent glutamate transport activity. Neurochem. Int. 37, 147 162.
40. Paxinos G. Watson C. (1998) The Rat Brain in Stereotaxic Coordinates, 4th edn. Academic Press, San Diego, CA.
41. Pristupa Z. B., McConkey F., Liu F., Man H. Y., Lee F. J. S., Wang Y. T. Niznik H. B. (1998) Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter. Synapse 30, 79 87.
42. Quick M. W. (2002) Substrates regulate gamma-aminobutyric acid transporters in a syntaxin 1A-dependent manner. Proc. Natl Acad. Sci. USA 99, 5686 5691.
43. Robinson D. L. Wightman R. M. (2004) Nomifensine amplifies subsecond dopamine signals in the ventral striatum of freely-moving rats. J. Neurochem. 90, 894 903.
44. Sabeti J., Adams C. E., Burmeister J., Gerhardt G. A. Zahniser N. R. (2002) Kinetic analysis of striatal clearance and exogenous dopamine recorded by chronoamperometry in freely-moving rats. J. Neurosci. Methods 121, 41 52.
45. Tong W., Igarashi T., Ferriero D. M. Noble L. J. (2002) Traumatic brain injury in the immature mouse brain: characterization of regional vulnerability. Exp. Neurol. 176, 105 116.
46. Torres G. E., Carneiro A., Seamans K. et al. (2003) Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter. J. Biol. Chem. 278, 2731 2739.
47. Vander Borght T., Kilbourn M., Desmond T., Kuhl D. Frey K. (1995) The vesicular monoamine transporter is not regulated by dopaminergic drug treatments. J. Eur. Pharmacol. 294, 577 583.
48. Venton B. J., Zhang H., Garris P. A., Philips P. E., Sulzer D. Wightman R. M. (2003) Real-time decoding of dopamine concentration changes in the caudate-putamen during tonic and phasic firing. J. Neurochem. 87, 1284 1295.
49. Volz T. J., Farnsworth S. J., King J. L., Riddle E. L., Hanson G. R. Fleckenstein A. E. (2007) Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesicles. J. Pharmacol. Exp. Ther. 323, 738 745.
50. Volz T. J., Farnsworth S. J., Rowley S. D., Hanson G. R. Fleckenstein A. E. (2008) Methylphenidate induced increases in vesicular dopamine sequestration and dopamine release in the striatum: the role of muscarinic and D2 receptors. J. Pharmacol. Exp. Ther. 327, 161 167.
51. Wagner A. K., Sokoloski J. E., Ren D., Chen X., Khan A. S., Zafonte R. D., Michael A. C. Dixon C. E. (2005a) Controlled cortical impact injury affects dopaminergic transmission in the rat striatum. J. Neurochem. 95, 457 465.
52. Wagner A. K., Chen X., Kline A. E., Li Y., Zafonte R. D. Dixon C. E. (2005b) Gender and environmental enrichment impact dopamine transporter expression after experimental traumatic brain injury. Exp. Neurol. 195, 475 483.
53. Wagner A. K., Kline A. E., Ren D., Willard L. A., Wenger M. K., Zafonte R. D. Dixon C. E. (2007) Gender associations with chronic methylphenidate treatment and behavioral performance following experimental TBI. Behav. Brain Res. 181, 200 209.
54. Warden D. L., Gordon B., McAllister T. W. et al. (2006) Guidelines for the pharmacologic treatment of neurobehavioral sequelae of traumatic brain injury. J. Neurotrauma 23, 1468 1501.
55. Whyte J., Hart T., Schuster K., Fleming M., Polansky M. Coslett H. B. (1997) Effects of methylphenidate on attentional function after traumatic brain injury. A randomized, placebo-controlled trial. Am. J. Phys. Med. Rehabil. 76, 440 450.
56. Whyte J., Hart T., Vaccaro M., Grieb-Neff P., Risser A., Polansky M. Coslett H. B. (2004) Effects of methylphenidate on attention deficits after traumatic brain injury: a multidimensional, randomized, controlled trial. Am. J. Phys. Med. Rehabil. 83, 401 420.
57. Wightman R. M. Zimmerman J. B. (1990) Control of dopamine extracellular concentration in rat striatum by impulse flow and uptake. Brain Res. Brain Res. Rev. 15, 135 144.
58. Wightman R. M., Heien M. L., Wassum K. M., Sombers L. A., Aragona B. J., Khan A. S., Ariansen J. L., Cheer J. F., Phillips P. E. Carelli R. M. (2007) Dopamine release is heterogeneous within microenvironments of the rat nucleus accumbens. Eur. J. Neurosci. 26, 2046 2054.
59. Williams J. M. Galli A. (2006) The dopamine transporter: a vigilant border control for psychostimulant action. Handb. Exp. Pharmacol. 175, 215 232.
60. Wilson M. S., Chen X., Ma X., Ren D., Wagner A. K., Reynolds I. J. Dixon C. E. (2005) Synaptosomal dopamine uptake in rat striatum following controlled cortical impact. J. Neurosci. Res. 80, 85 91.
61. Wu Q., Reith M. E. A., Wightman R. M., Kawagoe K. T. Garris P. A. (2001) Determination of release and uptake parameters from electrically evoked dopamine dynamics measured by real-time voltammetry. J. Neurosci. Methods 112, 119 133.
62. Yan H. Q., Ma X., Chen X., Li Y., Shao L. Dixon C. E. (2007) Delayed increase of tyrosine hydroxylase expression in rat nigrostriatal system after traumatic brain injury. Brain Res. 1134, 171 179.
63. Yang K., Mu X. S., Xue J. J., Whitson J., Salminen A., Dixon C. E., Liu P. K. Hayes R. L. (1994) Increased expression of c-fos mRNA and AP-1 transcription factors after cortical impact injury in rats. Brain Res. 664, 141 147.
64. Yang H., Peters J. L. Michael A. C. (1998) Coupled effects of mass transfer and uptake kinetics on in vivo microdialysis of dopamine. J. Neurochem. 71, 684 692.
65. Yatin S. M., Miller G. M., Norton C. Madras B. (2002) Dopamine Transporter-dependent induction of c-Fos in HEK cells. Synapse 45, 52 65.
66. Yatin S. M., Miller G. M. Madras B. K. (2005) Dopamine and norepinephrine transporter-dependent c-Fos production in vitro: relevance to neuroadaptation. J. Neurosci. Methods 143, 69 78.
67. Yi J. J. Ehlers M. D. (2005) Ubiquitin and protein turnover in synapse function. Neuron 47, 629 632.
68. --dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol. Ther. 92, 21 55.
69. Zhu J., Apparsundaram S., Bardo M. T. Dwoskin L. P. (2005) Environmental enrichment decreases cell surface expression of the dopamine transporter in rat medial prefrontal cortex. J. Neurochem. 93, 1434 1443.
70. Zhuang X., Oosting R. S., Jones S. R., Gainetdinov R. R., Miller G. W., Caron M. G. Hen R. (2001) Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc. Natl Acad. Sci. USA 98, 1982 1987.